Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Parallel Importation

This article was originally published in SRA

Executive Summary

Revised guideline on import permits

You may also be interested in...

Lannett Bets On Respiratory And Insulins Pipeline As Sales Falter

Despite turnover dropping by over a fifth in its financial third quarter, Lannett says it is optimistic that respiratory generics and insulins will offer the firm “durable” opportunities in future. The company has also just reorganized its finances to extend its debt maturity by four years, pushing it back past some of its key launches.

LATAM Q1 Sales: Mexico's Genomma And Brazil's Hypera Report Gains

Genomma Lab reports OTC sales rise in Q1 thanks to gains in its LATAM region, while Brazil's Hypera posts big jump in turnover due to acquisitions. 

Executives On The Move: New CEOs At Advicenne, Almirall And CohBar

Executive reshuffle at Karyopharm Therapeutics, plus new chief financial officers at Redx Pharma and Vaccibody.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts